Leuko Labs, Inc.

Leuko is developing PointCheck™, a noninvasive, light-based device that measures white blood cell levels through a finger-based test without requiring a blood draw. The investigational device is designed for at-home use and aims to help cancer patients and clinicians identify infection risk early through AI analysis of blood flow in superficial capillaries.